Sorriso Pharmaceuticals
PrivateLast Round
Series A
Dec 22, 2021
Est. Valuation
$50M
Total Funding Raised
$31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sorriso Pharmaceuticals is a biopharmaceutical company developing oral disease-modifying antibodies for the treatment of inflammatory diseases such as Crohn's disease and ulcerative colitis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sorriso Pharmaceuticals Comparables
Compare Sorriso Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caldera Therapeutics | 88% | |
| GAT Biosciences S.L. | 86% | |
| Mage Biologics Inc. | 84% |
Sorriso Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 22, 2021 |
Sorriso Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| A. M. Pappas & Associates | Series A |
| New Enterprise Associates | Series A |
| Lundbeckfonden BioCapital | Series A |
| Arix Bioscience | Series A |
| Biovision Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 34% MoM, reaching 1.8K.
- Apr 18, 2026
Monthly visitors increased 42% MoM.
Sorriso Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sorriso Pharmaceuticals's valuation, stock price, and market status.
Is Sorriso Pharmaceuticals a public or private company?
Sorriso Pharmaceuticals is a private company.
What is the current stock price of Sorriso Pharmaceuticals?
Sorriso Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Sorriso Pharmaceuticals worth (valuation)?
Sorriso Pharmaceuticals's valuation is estimated at $50.0M based on funding round data.
Can I buy Sorriso Pharmaceuticals stock?
Sorriso Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sorriso Pharmaceuticals's last funding round?
Sorriso Pharmaceuticals's most recent funding round was Series A on December 22, 2021.
Who are the main investors in Sorriso Pharmaceuticals?
Key investors in Sorriso Pharmaceuticals include New Enterprise Associates (NEA), Arix Bioscience.
Will Sorriso Pharmaceuticals IPO soon?
No public IPO plans have been announced for Sorriso Pharmaceuticals.
How can I track Sorriso Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sorriso Pharmaceuticals's secondary market activity and sign up for updates.